BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26233944)

  • 41. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic Strategies After Bioprosthetic Aortic Valve Replacement: A Systematic Review.
    Papak JN; Chiovaro JC; Noelck N; Healy LD; Freeman M; Quin JA; Paynter R; Low A; Kondo K; McCarty OJT; Kansagara D
    Ann Thorac Surg; 2019 May; 107(5):1571-1581. PubMed ID: 30458159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties.
    Iung B; Rodés-Cabau J
    Eur Heart J; 2014 Nov; 35(42):2942-9. PubMed ID: 25205532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose acetyl salicylic acid versus oral anticoagulation after bioprosthetic aortic valve replacement. Final report of the ACTION registry.
    Colli A; Verhoye JP; Heijmen R; Antunes M;
    Int J Cardiol; 2013 Sep; 168(2):1229-36. PubMed ID: 23237759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.
    Durães AR; Durães MA; Correia LC; Aras R
    Arq Bras Cardiol; 2013 Nov; 101(5):466-72. PubMed ID: 24100694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombotic therapy in children and adolescents.
    Woods A; Vargas J; Berri G; Kreutzer G; Meschengieser S; Lazzari MA
    Thromb Res; 1986 May; 42(3):289-301. PubMed ID: 3715804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.
    Chiang YP; Chikwe J; Moskowitz AJ; Itagaki S; Adams DH; Egorova NN
    JAMA; 2014 Oct; 312(13):1323-9. PubMed ID: 25268439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial fibrillation at mid-term after bioprosthetic aortic valve replacement – implications for anti-thrombotic therapy.
    Tosello F; Florens E; Caruba T; Lebeller C; Mimoun L; Milan A; Fabiani JN; Boutouyrie P; Menasché P; Lillo-Lelouet A
    Circ J; 2015; 79(1):70-6. PubMed ID: 25482295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
    Vaughan P; Waterworth PD
    J Heart Valve Dis; 2005 Sep; 14(5):576-82. PubMed ID: 16245494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement?
    Tourmousoglou C; Rao V; Lalos S; Dougenis D
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):837-43. PubMed ID: 25754372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.
    Weber A; Noureddine H; Englberger L; Dick F; Gahl B; Aymard T; Czerny M; Tevaearai H; Stalder M; Carrel TP
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1075-83. PubMed ID: 22341653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry - POL-TAVI.
    Czerwińska-Jelonkiewicz K; Zembala M; Dąbrowski M; Witkowski A; Ochała A; Kochman J; Dudek D; Kübler P; Jagielak D; Stępińska J
    Int J Cardiol; 2017 Jan; 227():305-311. PubMed ID: 27843052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to define valvular atrial fibrillation?
    Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
    Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy.
    Van Nooten GJ; Caes F; François K; Van Bellleghem Y; Bové T; Vandenplas G; Taeymans Y
    J Heart Valve Dis; 2012 Jan; 21(1):88-98. PubMed ID: 22474748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    Obayashi Y; Miyake M; Amano M; Kitai T; Takegami M; Nishimura K; Tamura T; Furukawa Y; Izumi C
    J Cardiol; 2022 Feb; 79(2):226-232. PubMed ID: 34716054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
    Puskas JD; Gerdisch M; Nichols D; Fermin L; Rhenman B; Kapoor D; Copeland J; Quinn R; Hughes GC; Azar H; McGrath M; Wait M; Kong B; Martin T; Douville EC; Meyer S; Ye J; Jamieson WRE; Landvater L; Hagberg R; Trotter T; Armitage J; Askew J; Accola K; Levy P; Duncan D; Yanagawa B; Ely J; Graeve A;
    J Am Coll Cardiol; 2018 Jun; 71(24):2717-2726. PubMed ID: 29903344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale, Design, and Baseline Characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study.
    Furukawa Y; Miyake M; Fujita T; Koyama T; Takegami M; Kimura T; Sugio K; Takita A; Nishimura K; Izumi C;
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):689-696. PubMed ID: 32710129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
    Christersson C; James SK; Lindhagen L; Ahlsson A; Friberg Ö; Jeppsson A; Ståhle E
    Heart; 2020 Jun; 106(11):838-844. PubMed ID: 31757813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary embolism due to probable clinical bioprosthetic aortic valve thrombosis: a case report.
    Ananda RA; Zhang Z
    BMC Cardiovasc Disord; 2023 Jun; 23(1):324. PubMed ID: 37365533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.